Search research articles
Contact Us
Filters
Showing results (21-30 of 99) with videos related to
Page
of 10
Sort By:
American Heart Journal
|
December 11, 2019
Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction
Dan Yang, Connor Galen O'Brien, Gentaro Ikeda, et al.
Minnesota Medicine
|
February 14, 2008
Emerging therapies for refractory angina
Daniel Satran, Jay H Traverse, Gregory W Barsness, et al.
The American Journal of Cardiology
|
June 17, 2020
Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry)
Katelyn M Storey, Julia Wang, Ross F Garberich, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 7, 2018
Revascularization in "no option" patients with refractory angina: Frequency, etiology and outcomes
Rahul Sharma, Michael Tradewell, Louis P Kohl, et al.
American Heart Journal
|
May 28, 2018
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design
Amish N Raval, Thomas D Cook, Henricus J Duckers, et al.
Stem Cells Translational Medicine
|
June 13, 2020
CD34<sup>+</sup> cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina
Grace L Johnson, Timothy D Henry, Thomas J Povsic, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 9, 2022
Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarction
Nicole L Bonfig, Chase R Soukup, Ananya A Shah, et al.
Circulation Research
|
August 22, 2014
Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy
Timothy D Henry, Jay H Traverse, Baron L Hammon, et al.
Journal of Cardiovascular Translational Research
|
December 8, 2010
Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction
Santiago Garcia, Timothy D Henry, Yale L Wang, et al.
Circulation
|
January 7, 2014
ST-elevation myocardial infarction diagnosed after hospital admission
Ross F Garberich, Jay H Traverse, Michael T Claussen, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 99) with videos related to
Sort By:
Page
of 10
American Heart Journal
|
December 11, 2019
Meta-analysis of short- and long-term efficacy of mononuclear cell transplantation in patients with myocardial infarction
Dan Yang, Connor Galen O'Brien, Gentaro Ikeda, et al.
Minnesota Medicine
|
February 14, 2008
Emerging therapies for refractory angina
Daniel Satran, Jay H Traverse, Gregory W Barsness, et al.
The American Journal of Cardiology
|
June 17, 2020
Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry)
Katelyn M Storey, Julia Wang, Ross F Garberich, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|
August 7, 2018
Revascularization in "no option" patients with refractory angina: Frequency, etiology and outcomes
Rahul Sharma, Michael Tradewell, Louis P Kohl, et al.
American Heart Journal
|
May 28, 2018
The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post-myocardial infarction heart failure: Trial rationale and study design
Amish N Raval, Thomas D Cook, Henricus J Duckers, et al.
Stem Cells Translational Medicine
|
June 13, 2020
CD34<sup>+</sup> cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina
Grace L Johnson, Timothy D Henry, Thomas J Povsic, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
September 9, 2022
Increasing myocardial edema is associated with greater microvascular obstruction in ST-segment elevation myocardial infarction
Nicole L Bonfig, Chase R Soukup, Ananya A Shah, et al.
Circulation Research
|
August 22, 2014
Safety and efficacy of ixmyelocel-T: an expanded, autologous multi-cellular therapy, in dilated cardiomyopathy
Timothy D Henry, Jay H Traverse, Baron L Hammon, et al.
Journal of Cardiovascular Translational Research
|
December 8, 2010
Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction
Santiago Garcia, Timothy D Henry, Yale L Wang, et al.
Circulation
|
January 7, 2014
ST-elevation myocardial infarction diagnosed after hospital admission
Ross F Garberich, Jay H Traverse, Michael T Claussen, et al.
Page
of 10